Beovu (brolucizumab-dbll)

Adult Dosing .

Dosage forms:  INJ (pre-filled syringe): 6 mg per 0.05 mL; INJ (vial): 6 mg per 0.05 mL

Special Note

[drug name clarification]

Info: nonproprietary name = brolucizumab-dbll

age-related macular degeneration, neovascular

[6 mg intravitreally q8-12wk]

Start: 6 mg intravitreally qmo x3 doses

diabetic macular edema

[6 mg intravitreally q8-12wk]

Start: 6 mg intravitreally q6wk x5 doses

renal dosing

[no adjustment]

renal impairment: no adjustment

HD/PD: no adjustment; no supplement

hepatic dosing

[no adjustment]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.